메뉴 건너뛰기
Lupus
Volumn 22, Issue 8, 2013, Pages 865-867
Rituximab therapy for recurrent thromboembolic disease in antiphospholipid syndrome
Author keywords

[No Author keywords available]
Indexed keywords

ANTINUCLEAR ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; D DIMER; DABIGATRAN; HEPARIN; PHOSPHOLIPID ANTIBODY; RITUXIMAB; WARFARIN;
EID: 84879705936     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313491023     Document Type: Letter
Times cited : (24)
References (10)
  • 1
    • 0027292423 scopus 로고
    • The antiphospholipid syndrome: Ten years on
    • Hughes G. The antiphospholipid syndrome: Ten years on. Lancet. 1993 ; 342: 341-344
    • (1993) Lancet , vol.342 , pp. 341-344
    • Hughes, G.1
  • 2
    • 60149101072 scopus 로고    scopus 로고
    • Controversies in the antiphospholipid syndrome: Can we ever stop warfarin?
    • Fonseca A, D'Cruz DP. Controversies in the antiphospholipid syndrome: Can we ever stop warfarin?. J Autoimmune Dis. 2008 ; 5: 6-6
    • (2008) J Autoimmune Dis , vol.5 , pp. 6-6
    • Fonseca, A.1    D'Cruz, D.P.2
  • 3
    • 59649112647 scopus 로고    scopus 로고
    • Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome
    • Martinuzzo M, Forastiero R. Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome. Lupus. 2008 ; 17: 872-872
    • (2008) Lupus , vol.17 , pp. 872-872
    • Martinuzzo, M.1    Forastiero, R.2
  • 4
    • 33744982646 scopus 로고    scopus 로고
    • Remission of severe anti-phospholipid syndrome associated with non-Hodgkin B cell lymphoma after combined treatment with Rituximab and chemotherapy
    • Veneri D, Ambrosetti A, Franchini M, et al. Remission of severe anti-phospholipid syndrome associated with non-Hodgkin B cell lymphoma after combined treatment with Rituximab and chemotherapy. Haematologica. 2005 ; 90: 16-17
    • (2005) Haematologica , vol.90 , pp. 16-17
    • Veneri, D.1    Ambrosetti, A.2    Franchini, M.3
  • 5
    • 30644467368 scopus 로고    scopus 로고
    • Successful treatment of thrombocytopenia in Primary APS with anti-CD20 antibody Rituximab-monitoring on antiphospholipid and anti-GP antibodies: A case report
    • Trappe R, Loew A, Thuss-Patience P, et al. Successful treatment of thrombocytopenia in Primary APS with anti-CD20 antibody Rituximab-monitoring on antiphospholipid and anti-GP antibodies: A case report. Ann Hematol. 2006 ; 85: 134-135
    • (2006) Ann Hematol , vol.85 , pp. 134-135
    • Trappe, R.1    Loew, A.2    Thuss-Patience, P.3
  • 6
    • 32144435725 scopus 로고    scopus 로고
    • Rituximab treatment for resistant antiphospholipid syndrome
    • Rubenstein E, Arkfeld DG, Metyas S, et al. Rituximab treatment for resistant antiphospholipid syndrome. J Rheumatol. 2006 ; 33: 355-357
    • (2006) J Rheumatol , vol.33 , pp. 355-357
    • Rubenstein, E.1    Arkfeld, D.G.2    Metyas, S.3
  • 7
    • 0142087478 scopus 로고    scopus 로고
    • Successful long term treatment of systemic lupus erythematosus with rituximab maintenance therapy
    • Weide R, Heymanns J, Pandorf A, et al. Successful long term treatment of systemic lupus erythematosus with rituximab maintenance therapy. Lupus. 2003 ; 12: 779-782
    • (2003) Lupus , vol.12 , pp. 779-782
    • Weide, R.1    Heymanns, J.2    Pandorf, A.3
  • 8
    • 41749105516 scopus 로고    scopus 로고
    • Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: A case report and a review of literature
    • Erre GL, Pardini S, Faedda R, et al. Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: A case report and a review of literature. Lupus. 2008 ; 1: 50-55
    • (2008) Lupus , vol.1 , pp. 50-55
    • Erre, G.L.1    Pardini, S.2    Faedda, R.3
  • 9
    • 0036668252 scopus 로고    scopus 로고
    • Humoral immunity and long lived plasma cells
    • Manz RA, Arce S, Cassese G, et al. Humoral immunity and long lived plasma cells. Curr Opinion Immunol. 2002 ; 14: 517-521
    • (2002) Curr Opinion Immunol , vol.14 , pp. 517-521
    • Manz, R.A.1    Arce, S.2    Cassese, G.3
  • 10
    • 84873846125 scopus 로고    scopus 로고
    • A pilot open-label phase 11 trial of rituximab for non-criteria manifestations of antiphospholipid syndrome
    • Eekan D, Vega J, Ramon G, et al. A pilot open-label phase 11 trial of rituximab for non-criteria manifestations of antiphospholipid syndrome. Arthritis Rheum. 2013 ; 65: 464-471
    • (2013) Arthritis Rheum , vol.65 , pp. 464-471
    • Eekan, D.1    Vega, J.2    Ramon, G.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.